.After antibody-drug conjugate (ADC) professional Seagen was actually offered to Pfizer in 2015 for ...
.On the heels of a phase 3 gain that fell short to wow financiers, Ironwood Pharmaceuticals is actua...
.Don't cease Monte Rosa Therapies now. The Boston-based biotech is actually enjoying after signing a...
.Invite to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings a...
.Commemorating his company's upsized initial public offering (IPO), Septerna chief executive officer...
.AbbVie has returned to the resource of its antipsychotic giant Vraylar trying to find another smash...
.GenSight Biologics is full weeks far from running out of cash. Again. The biotech merely has adequa...
.Monopar Rehabs is bouncing back a medicine from the scrap heap of AstraZeneca's rare disease pipeli...
.Along with brand-new information out on Arcus Biosciences' experimental HIF-2a prevention, one team...
.After creating a gene therapy alliance with Dyno Therapeutics in 2020, Roche is back for additional...